Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William C Adams

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Cell Reports|November 10, 2016
CD8<sup>+</sup> T Lymphocyte Self-Renewal during Effector Cell DeterminationWen-Hsuan W Lin, Simone A Nish, Bonnie Yen, et al.
The Journal of Experimental Medicine|September 7, 2006
PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infectionConstantinos Petrovas, Joseph P Casazza, Jason M Brenchley, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 5, 2013
Human plasmacytoid dendritic cells efficiently capture HIV-1 envelope glycoproteins via CD4 for antigen presentationKerrie J Sandgren, Anna Smed-Sörensen, Mattias N Forsell, et al.
The Journal of Investigative Dermatology|August 19, 2011
Plasmacytoid dendritic cells infiltrate the skin in positive tuberculin skin test indurationsEmily Bond, Frank Liang, Kerrie J Sandgren, et al.
The Journal of Experimental Medicine|December 8, 2016
CD4+ T cell effector commitment coupled to self-renewal by asymmetric cell divisionsSimone A Nish, Kyra D Zens, Radomir Kratchmarov, et al.
Journal of Virology|October 5, 2007
Dendritic cells are less susceptible to human immunodeficiency virus type 2 (HIV-2) infection than to HIV-1 infectionMelody G Duvall, Karin Loré, Hetty Blaak, et al.
Cell Reports|December 24, 2016
Anabolism-Associated Mitochondrial Stasis Driving Lymphocyte Differentiation over Self-RenewalWilliam C Adams, Yen-Hua Chen, Radomir Kratchmarov, et al.
The New England Journal of Medicine|April 26, 2024
Subcutaneous Administration of a Monoclonal Antibody to Prevent MalariaKassoum Kayentao, Aissata Ongoiba, Anne C Preston, et al.
Nature Medicine|April 12, 2022
Safety and tolerability of AAV8 delivery of a broadly neutralizing antibody in adults living with HIV: a phase 1, dose-escalation trialJoseph P Casazza, Evan M Cale, Sandeep Narpala, et al.
Science Translational Medicine|April 19, 2023
An influenza hemagglutinin stem nanoparticle vaccine induces cross-group 1 neutralizing antibodies in healthy adultsAlicia T Widge, Amelia R Hofstetter, Katherine V Houser, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Cell Reports|November 10, 2016
CD8<sup>+</sup> T Lymphocyte Self-Renewal during Effector Cell DeterminationWen-Hsuan W Lin, Simone A Nish, Bonnie Yen, et al.
The Journal of Experimental Medicine|September 7, 2006
PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infectionConstantinos Petrovas, Joseph P Casazza, Jason M Brenchley, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 5, 2013
Human plasmacytoid dendritic cells efficiently capture HIV-1 envelope glycoproteins via CD4 for antigen presentationKerrie J Sandgren, Anna Smed-Sörensen, Mattias N Forsell, et al.
The Journal of Investigative Dermatology|August 19, 2011
Plasmacytoid dendritic cells infiltrate the skin in positive tuberculin skin test indurationsEmily Bond, Frank Liang, Kerrie J Sandgren, et al.
The Journal of Experimental Medicine|December 8, 2016
CD4+ T cell effector commitment coupled to self-renewal by asymmetric cell divisionsSimone A Nish, Kyra D Zens, Radomir Kratchmarov, et al.
Journal of Virology|October 5, 2007
Dendritic cells are less susceptible to human immunodeficiency virus type 2 (HIV-2) infection than to HIV-1 infectionMelody G Duvall, Karin Loré, Hetty Blaak, et al.
Cell Reports|December 24, 2016
Anabolism-Associated Mitochondrial Stasis Driving Lymphocyte Differentiation over Self-RenewalWilliam C Adams, Yen-Hua Chen, Radomir Kratchmarov, et al.
The New England Journal of Medicine|April 26, 2024
Subcutaneous Administration of a Monoclonal Antibody to Prevent MalariaKassoum Kayentao, Aissata Ongoiba, Anne C Preston, et al.
Nature Medicine|April 12, 2022
Safety and tolerability of AAV8 delivery of a broadly neutralizing antibody in adults living with HIV: a phase 1, dose-escalation trialJoseph P Casazza, Evan M Cale, Sandeep Narpala, et al.
Science Translational Medicine|April 19, 2023
An influenza hemagglutinin stem nanoparticle vaccine induces cross-group 1 neutralizing antibodies in healthy adultsAlicia T Widge, Amelia R Hofstetter, Katherine V Houser, et al.
Pageof 5